Loading...
Solventum Corporation
SOLV•NYSE
HealthcareMedical - Care Facilities
$74.84
$-0.53(-0.70%)
Solventum Corporation (SOLV) Financial Performance & Statements
Review Solventum Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.70%
↑ 0.70%
Operating Income Growth
-38.77%
↓ 38.77%
Net Income Growth
-64.41%
↓ 64.41%
Operating Cash Flow Growth
-38.12%
↓ 38.12%
Operating Margin
9.71%
↑ 9.71%
Gross Margin
54.59%
↑ 54.59%
Net Profit Margin
4.55%
↑ 4.55%
ROE
12.31%
↑ 12.31%
ROIC
6.75%
↑ 6.75%
Solventum Corporation (SOLV) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Solventum Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.07B | $2.08B | $2.08B | $2.02B |
| Cost of Revenue | $955.00M | $917.00M | $944.00M | $843.00M |
| Gross Profit | $1.12B | $1.17B | $1.14B | $1.17B |
| Gross Profit Ratio | $0.54 | $0.56 | $0.55 | $0.58 |
| R&D Expenses | $199.00M | $189.00M | $192.00M | $195.00M |
| SG&A Expenses | $784.00M | $701.00M | $701.00M | $596.00M |
| Operating Expenses | $983.00M | $890.00M | $893.00M | $791.00M |
| Total Costs & Expenses | $1.94B | $1.81B | $1.84B | $1.63B |
| Interest Income | $0.00 | $0.00 | $114.00M | $0.00 |
| Interest Expense | $107.00M | $107.00M | $114.00M | $39.00M |
| Depreciation & Amortization | $148.00M | $133.00M | $133.00M | $139.00M |
| EBITDA | $268.00M | $407.00M | $377.00M | $520.00M |
| EBITDA Ratio | $0.13 | $0.20 | $0.18 | $0.26 |
| Operating Income | $136.00M | $275.00M | $244.00M | $382.00M |
| Operating Income Ratio | $0.07 | $0.13 | $0.12 | $0.19 |
| Other Income/Expenses (Net) | -$123.00M | -$108.00M | -$148.00M | -$52.00M |
| Income Before Tax | $13.00M | $167.00M | $96.00M | $329.00M |
| Income Before Tax Ratio | $0.006 | $0.08 | $0.05 | $0.16 |
| Income Tax Expense | -$17.00M | $45.00M | $7.00M | $92.00M |
| Net Income | $30.00M | $122.00M | $89.00M | $237.00M |
| Net Income Ratio | $0.01 | $0.06 | $0.04 | $0.12 |
| EPS | $0.17 | $0.70 | $0.51 | $1.37 |
| Diluted EPS | $0.17 | $0.70 | $0.51 | $1.37 |
| Weighted Avg Shares Outstanding | $173.40M | $173.40M | $173.20M | $172.70M |
| Weighted Avg Shares Outstanding (Diluted) | $174.50M | $173.90M | $173.50M | $172.70M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan